This brand name is authorized in Canada, Ecuador, Singapore, United States
The drug PAZEO contains one active pharmaceutical ingredient (API):
1
Olopatadine
UNII 2XG66W44KF - OLOPATADINE HYDROCHLORIDE
|
Olopatadine is a potent selective antiallergic/antihistaminic agent that exerts its effects through multiple distinct mechanisms of action. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
PAZEO Ophthalmic solution | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
S01GX09 | Olopatadine | S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GX Other antiallergics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: CA | Health Products and Food Branch | Identifier(s): 02458551 |
Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 1883-MEE-0316 |
Country: SG | Health Sciences Authority | Identifier(s): 15242P |
Country: US | FDA, National Drug Code | Identifier(s): 0065-4273 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.